TradingKey

關於 Milestone Pharmaceuticals Inc 公司

Milestone Pharmaceuticals Inc. 是一家總部位於加拿大的生物製藥公司。該公司專注於心血管藥物的開發和商業化。其主要候選產品依曲帕米是一種強效速效鈣通道阻滯劑，該公司設計並正在開發一種速效鼻噴霧劑，供患者使用。該公司還專注於開發依曲帕米用於治療陣發性室上性心動過速 (PSVT)，隨後用於治療心房顫動伴快速心室率 (AFib-RVR) 和其他心血管適應症。

公司簡介

公司代碼MIST

公司名稱Milestone Pharmaceuticals Inc

上市日期May 09, 2019

CEOMr. Joseph Oliveto

員工數量33

證券類型Ordinary Share

年結日May 09

公司地址420-1111 boul. Dr.-Frederik-Philips

城市MONTREAL

上市交易所NASDAQ Global Select Consolidated

國家Canada

郵編H4M 2X6

電話15143360444

網址https://www.milestonepharma.com

公司代碼MIST

上市日期May 09, 2019

CEOMr. Joseph Oliveto

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. David Bharucha

Chief Medical Officer

78.45K

+212.30%

Mr. Amit Hasija

Chief Financial Officer, Executive Vice President - Corporate Development

69.20K

+260.35%

Dr. Robert James Wills, Ph.D.

Non-Executive Independent Chairman of the Board

65.00K

+333.33%

Mr. Michael John Tomsicek

Independent Director

15.00K

--

Mr. Stuart Duty

Independent Director

--

Mr. Joeseph C. Papa

Independent Director

--

Mr. Andrew Saik

Independent Director

--

Ms. Lisa M. Giles

Independent Director

--

Mr. Joseph Oliveto

President, Chief Executive Officer, Director

--

Mr. Lorenz Muller

Chief Commercial Officer

--

名稱

名稱/職務

職務

持股

持股變動

Dr. David Bharucha

Chief Medical Officer

78.45K

+212.30%

Mr. Amit Hasija

Chief Financial Officer, Executive Vice President - Corporate Development

69.20K

+260.35%

Dr. Robert James Wills, Ph.D.

Non-Executive Independent Chairman of the Board

65.00K

+333.33%

Mr. Michael John Tomsicek

Independent Director

15.00K

--

Mr. Stuart Duty

Independent Director

--

Mr. Joeseph C. Papa

Independent Director

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 7月26日週六

持股股東

股東類型

持股股東

佔比

Trails Edge Capital Partners LP

6.28%

Oliveto (Joseph Gerard)

2.95%

RTW Investments L.P.

2.95%

Propel Bio Management, LLC

1.71%

Alta Fundamental Advisers LLC

1.68%

Other

84.43%

持股股東

佔比

Trails Edge Capital Partners LP

6.28%

Oliveto (Joseph Gerard)

2.95%

RTW Investments L.P.

2.95%

Propel Bio Management, LLC

1.71%

Alta Fundamental Advisers LLC

1.68%

Other

84.43%

股東類型

持股股東

佔比

Investment Advisor

9.84%

Individual Investor

3.61%

Investment Advisor/Hedge Fund

3.37%

Hedge Fund

2.90%

Research Firm

2.38%

Venture Capital

1.77%

Bank and Trust

0.03%

Other

76.11%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

98

14.43M

18.73%

-14.88M

2025Q1

102

12.26M

22.94%

-17.24M

2024Q4

99

25.17M

47.19%

-9.38M

2024Q3

113

29.31M

55.02%

-13.44M

2024Q2

115

30.81M

57.87%

-11.80M

2024Q1

116

31.96M

60.43%

+3.19M

2023Q4

112

18.49M

55.02%

-13.59M

2023Q3

109

20.24M

60.32%

-12.06M

2023Q2

108

21.35M

63.87%

-11.78M

2023Q1

110

22.19M

66.58%

-11.98M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Oliveto (Joseph Gerard)

2.44M

4.57%

+2.16M

+756.94%

Apr 15, 2025

RTW Investments L.P.

2.51M

4.69%

--

Mar 31, 2025

Propel Bio Management, LLC

1.45M

2.71%

+1.25M

+625.78%

Mar 31, 2025

Alta Fundamental Advisers LLC

1.43M

2.67%

-1.23M

-46.31%

Mar 31, 2025

BML Capital Management LLC

1.14M

2.13%

--

Mar 31, 2025

Morgan Stanley & Co. LLC

965.92K

1.81%

-320.62K

-24.92%

Mar 31, 2025

Simplify Asset Management Inc

850.00K

1.59%

+850.00K

--

Mar 31, 2025

TD Securities, Inc.

750.00K

1.4%

--

Mar 31, 2025

Lion Point Capital, L.P.

548.81K

1.03%

-477.00K

-46.50%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Simplify Propel Opportunities ETF

2.84%

SPDR S&P International Small Cap ETF

0.01%

Avantis US Small Cap Equity ETF

0%

Simplify Propel Opportunities ETF

佔比2.84%

SPDR S&P International Small Cap ETF

佔比0.01%

Avantis US Small Cap Equity ETF

佔比0%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Milestone Pharmaceuticals Inc

1.490USD

Milestone Pharmaceuticals Inc

1.490

概覽

公司

財務